TAM
Tanami Gold NL
π¦πΊ ASX
βοΈ MINING
π Overview
π Performance
π΅ Cost
π Esg
π€ Advanced
π¨βπ©βπ§βπ¦ Community
π
-9.06%
Annual Growth
5 years average annual growth
π΅
$ 500
Minimum Order
Due to regulatory requirements
π
1
Pearlers Invested
Since January 2020
π Overview
Key information
π Fund Overview
Tanami Gold NL engages in gold mining operations and mineral exploration. The company is headquartered in Perth, Western Australia. The firm has a 50% interest in the Central Tanami Project Joint Venture (CTPJV) located in the Tanami Desert in the Northern Territory. The Central Tanami Project (CTP) is located 650 kilometers northwest of Alice Springs in the Tanami Region of the Northern Territory. The company comprises a series of tenements that collectively cover an area of approximately 2,211 square kilometers (km2) area held in the Tanami Region in the Northern Territory. The tenement holding encompasses prospective, underexplored geological sequences in an area that is known to be well endowed with gold mineralization.
π Performance
Price History
+70.59%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
ποΈ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out βπ΅ Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out ββ±οΈ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out βπ΅ Costs
πΌ
N/A
Management Fee
Included in unit price, not charged by Pearler
πΈ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πΈ Net fee calculatorπ Environmental, Social and Governance scores βΉοΈ
π³
Environmental Score
4
A measure of an organisations or investment's impact on the natural environment, including factors such as carbon emissions, resource usage, and pollution
βοΈ
Governance Score
25
An evaluation of an organisations impact on society, focusing on factors such as employee welfare, diversity and inclusion, community engagement, and product safety and quality.
π€ Advanced information
Technical Info
π° Price*
$0.03
*Price may be up to 24 hours old
π©βπ©βπ¦ Community Insights
How our community is investing
π Pearlers invested in TAM
1
π Total Capital Earnings
N/A
π Average investment frequency
30 weeks
π΅ Average investment amount
$95
β° Last time a customer invested in TAM
1208 days
TAM investor breakdown
π΅ Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
100%
Less than 50k
πΆ Age of investors
18 - 25
26 - 34
35 - 90
100%
π Legal gender of investors
Female
Male
100%
Pearlers who invest in TAM also invest in...
QUAL.AX was created on 2014-10-29 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. Each Fund aims to provide investment returns before fees and other costs which track the performance of its Reference Index in Australian dollars.
π Performance (5Yr p.a)
15.98%
π Share price
$59.18 AUD
π€ TECHNOLOGY
π GLOBAL
π COMMUNICATIONS
π HIGH PRICE GROWTH
IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
π Performance (5Yr p.a)
17.84%
π Share price
$63.14 AUD
π HIGH PRICE GROWTH
πΊπΈ UNITED STATES
Actinogen Medical Ltd. is a clinical stage Australian biotechnology company, which focuses on the development of novel treatments or cognitive impairment associated with neurological, psychiatric, and metabolic diseases due to raised cortisol. The company is headquartered in Sydney, New South Wales. The company went IPO on 2007-10-16. The firm is engaged in the development of a therapy for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol. The firm is engaged in the development of its lead compound, Xanamem, as a therapy for Alzheimerβs Disease, Major Depressive Disorder, Fragile X Syndrome, and other neurological diseases where reducing cortisol inside brain cells could have a positive impact. Xanamemβs mechanism of action is to block the production of cortisol inside cells through the inhibition of the 11B-HSD1 enzyme in the brain. Xanamem is designed to get into the brain after it is absorbed in the intestines upon swallowing its capsule. The company has studied 11B-HSD1 inhibition by Xanamem in approximately 300 volunteers and patients. The firm conducts a series of Phase II studies in multiple diseases to further confirm and characterize Xanamemβs therapeutic potential.
π Performance (5Yr p.a)
6.04%
π Share price
$0.04 AUD
𧬠BIOTECHNOLOGY
π HIGH PRICE GROWTH
Alumina Ltd. engages in the business of bauxite mining and alumina refining. The company is headquartered in Southbank, Victoria. The principal activities of the Company relate to its 40% interest in the series of operating entities forming AWAC. AWAC has interests in bauxite mining, alumina refining and aluminum smelting. The firm is the 40% partner in the AWAC joint venture with a portfolio of assets in Australia, Brazil, Spain, Saudi Arabia, and Guinea, including global bauxite mines and alumina refineries. AWAC also has a 55% interest in the Portland aluminum smelter in Victoria, Australia. Its subsidiaries include Alumina Employee Share Plan Pty Ltd, Alumina Finance Pty Ltd., Alumina Holdings (USA) Inc., Alumina International Holdings Pty. Ltd., Alumina Brazil Holdings Pty Ltd, Alumina Limited Do Brasil SA, Alumina (U.S.A.) Inc., Butia Participacoes SA, and Westminer Acquisition (U.K.) Limited.
π Performance (5Yr p.a)
-6.94%
π Share price
$1.45 AUD
βοΈ MINING
VESG.AX was created on 2018-09-11 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Ethically Conscious International Shares Index ETF seeks to track the return of the FTSE Developed ex Australia Choice Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax
π Performance (5Yr p.a)
13.78%
π Share price
$102.53 AUD
π GLOBAL
π€ TECHNOLOGY
β³οΈ DIVERSIFIED
π HIGH PRICE GROWTH
Want more shares? Try these...
Talius Group Ltd. engages in the provision of technology enabled services to the aged care industry. The Companyβs software as a service (SaaS) data analytics platform, Talius Smart Care, combines smart sensors with artificial intelligence (AI) machine learning that delivers automated actions. Its customized AI analysis uses predicative interpretation and monitors a range of indicators such as sleep, vital signs, falls, activities of daily living and social interaction. The company links awareness, analysis, and action through one platform, allowing the care model to move from spot check care to sense-respond care. The company helps protect and connect its elderly and people with disabilities with a scalable healthcare technology platform integrated with third-party providers to ensure end-to-end solutions for Connected Health.
π Performance (5Yr p.a)
12.00%
π Share price
$0.01 AUD
π HIGH PRICE GROWTH
π€ TECHNOLOGY
ποΈ
Social Score
12
An assessment of an organisations management practices, board structure, transparency, and accountability, reflecting its commitment to ethical behavior and responsible decision-making.